Skip to main content
. 2020 Dec 6;9(1):1846915. doi: 10.1080/2162402X.2020.1846915

Figure 7.

Figure 7.

Mechanistic model of how inhibition of the MIF-CD74 axis overcomes resistance of melanoma cells to immune checkpoint blockade. Inhibition of MIF signaling reduces HIF-1α expression levels in resistant cell line (3I-F4) causing reprogramming of the glycolytic pathway by reducing lactate production influencing the TME structure to increase the efficacy of ICB